Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Alveolar Soft Part 1

Interventions

pembrolizumab 1255Specimen Handling 871Carboplatin 820Magnetic Resonance Spectroscopy 809Cyclophosphamide 799Cisplatin 719Nivolumab 645Paclitaxel 626Radiotherapy 565Gemcitabine 563Biopsy 532Bevacizumab 471Dexamethasone 435fludarabine 406Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 353Capecitabine 350atezolizumab 342Rituximab 329durvalumab 328Doxorubicin 314Radiosurgery 306Pemetrexed 303Drug Therapy 294Standard of Care 293Ipilimumab 288Etoposide 279Radiation 279

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Flurazepam × 1 year × Clear all
NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡